US 9968669
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
granted A61KA61K2039/53A61K2039/575
Quick answer
US patent 9968669 (Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome) held by The United States of America as represented by the Secretary of the Army expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/53, A61K2039/575, A61K2039/70, A61K39/12